Neurotrophic keratopathy: General features and new therapies.

被引:3
|
作者
Vera-Duarte, Guillermo Raul [1 ]
Jimenez-Collado, David [1 ]
Kahuam-Lopez, Nicolas [1 ]
Ramirez-Miranda, Arturo [1 ]
Graue-Hernandez, Enrique O. [1 ]
Navas, Alejandro [1 ]
Rosenblatt, Mark I. [2 ]
机构
[1] Inst Oftalmol Conde de Valenciana, Dept Cornea & Refract Surg, Mexico City, Mexico
[2] Univ Illinois Chicago UIC, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA
关键词
Neurotrophic Keratitis; Ocular surface disease; Corneal sensory innervation; Pathogenesis; Management; Corneal neurotization; AMNIOTIC MEMBRANE TRANSPLANTATION; PERSISTENT EPITHELIAL DEFECTS; VIVO-CONFOCAL-MICROSCOPY; AUTOLOGOUS SERUM APPLICATION; SCLERAL CONTACT-LENSES; PLATELET-RICH PLASMA; OCULAR SURFACE; DRY EYE; IN-VIVO; CORNEAL SENSITIVITY;
D O I
10.1016/j.survophthal.2024.04.004
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Neurotrophic keratopathy is an uncommon degenerative corneal disorder characterized by compromised corneal sensory innervation resulting in the formation of epithelial defects and nonhealing corneal ulcers. Various treatment modalities are available to stabilize disease progression, improve patient well-being, and prevent vision loss. For eligible patients, medical and surgical reinnervation have emerged as pioneering therapies, holding promise for better management. We present a comprehensive review of the disorder, providing an update relevant to ophthalmologists on pathogenesis, diagnosis, treatment options, and novel therapies targeting pathophysiological pathways.
引用
收藏
页码:789 / 804
页数:16
相关论文
共 50 条
  • [21] Neurotrophic keratopathy and diabetes mellitus
    Lockwood, A.
    Hope-Ross, M.
    Chell, P.
    EYE, 2006, 20 (07) : 837 - 839
  • [22] Treatment of chronic hepatitis B: new antiviral therapies.
    Yao F.
    Gish R.G.
    Current Gastroenterology Reports, 1999, 1 (1) : 20 - 26
  • [23] Metabolic profiling used for development of new diabetes therapies.
    Newgard, CB
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U152 - U152
  • [24] Development of new stroke therapies.: Outlook for neuroprotective drugs
    Rogalewski, A.
    Schaebitz, W. -R.
    NERVENARZT, 2008, 79 (02): : 218 - 224
  • [25] Cenegermin in Pediatric Neurotrophic Keratopathy
    Pedrotti, Emilio
    Bonetto, Jacopo
    Cozzini, Tiziano
    Fasolo, Adriano
    Marchini, Giorgio
    CORNEA, 2019, 38 (11) : 1450 - 1452
  • [26] Neurotrophic Keratopathy - Underdiagnosed and incurable?
    Geerling, G.
    OPHTHALMOLOGE, 2019, 116 (02): : 108 - 108
  • [27] Metabolic profiling used for development of new diabetes therapies.
    Newgard, CB
    BIOCHEMISTRY, 2003, 42 (28) : 8597 - 8597
  • [28] Genotypic and phenotypic features of de novo and acquired resistance to cancer therapies.
    Dancey, Janet E.
    CANCER RESEARCH, 2013, 73 (08)
  • [29] Neurotrophic keratopathy: An updated understanding
    Neurotrophic Keratopathy Study Grp
    OCULAR SURFACE, 2023, 30 : 129 - 138
  • [30] Treatment of Neurotrophic Keratopathy With Nicergoline
    Lee, Young-Chun
    Kim, Su-Young
    CORNEA, 2015, 34 (03) : 303 - 307